908 Devices Inc. (MASS)

NASDAQ: MASS · IEX Real-Time Price · USD
8.09
+0.04 (0.43%)
Mar 30, 2023, 10:16 AM EDT - Market open
0.43%
Market Cap 261.50M
Revenue (ttm) 46.85M
Net Income (ttm) -33.56M
Shares Out 32.05M
EPS (ttm) -1.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,969
Open 8.14
Previous Close 8.05
Day's Range 8.05 - 8.15
52-Week Range 6.38 - 26.00
Beta 0.62
Analysts Buy
Price Target 17.34 (+114.47%)
Earnings Date May 8, 2023

About MASS

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extra... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Dec 18, 2020
Employees 177
Stock Exchange NASDAQ
Ticker Symbol MASS
Full Company Profile

Financial Performance

In 2022, 908 Devices's revenue was $46.85 million, an increase of 11.01% compared to the previous year's $42.21 million. Losses were -$33.56 million, 51.4% more than in 2021.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for MASS stock is "Buy." The 12-month stock price forecast is $17.34, which is an increase of 114.47% from the latest price.

Price Target
$17.34
(114.47% upside)
Analyst Consensus: Buy
Stock Forecasts

News

908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of -40.91% and 1.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte...

3 weeks ago - Business Wire

908 Devices to Participate in the Cowen 43rd Annual Healthcare Conference

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming Cowen 43r...

1 month ago - Business Wire

908 Devices to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the four...

1 month ago - Business Wire

908 Devices Unveils New Glucose and Lactate On-Line Device for Bioprocess Monitoring and Control

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced the launch of MAVEN, a device for on-line m...

2 months ago - Business Wire

MX908 Device Enables Correctional Facility Personnel to Quickly Identify Illegal Drugs in Incoming Mail

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today shared details on the positi...

4 months ago - Business Wire

908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 9.09% and 0.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results f...

4 months ago - Business Wire

908 Devices Records Strong Momentum in Life Sciences Sector

BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, continues to equip its life science custo...

5 months ago - Business Wire

908 Devices Launches Pesticide Identification Capability to Thwart Illegal Marijuana Growing Operations

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the availability of ...

5 months ago - Business Wire

908 Devices to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate ...

5 months ago - Business Wire

908 Devices to Report Third Quarter 2022 Financial Results on November 14, 2022

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report finan...

5 months ago - Business Wire

908 Devices and CPI Improve mAbs Cell Culture Outcomes Using At-line Media Analysis

BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, announced that its collaboration with CPI is demons...

6 months ago - Business Wire

908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 0% and 2.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

908 Devices Reports Second Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for...

8 months ago - Business Wire

908 Devices Acquires TRACE Analytics, Enabling On-line Bioanalytics

BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announces that it has completed the...

8 months ago - Business Wire

908 Devices to Participate in the Canaccord Genuity 42nd Annual Growth Conference

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will be participa...

8 months ago - Business Wire

908 Devices to Report Second Quarter 2022 Financial Results on August 9, 2022

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report finan...

9 months ago - Business Wire

908 Devices Showcases Technology for Accelerating Mass Spec Workflows in Presentations at ASMS

BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, is showcasing the use of its high-pressur...

10 months ago - Business Wire

908 Devices to Participate in the William Blair 42nd Annual Growth Stock Conference

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will be participa...

11 months ago - Business Wire

908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 0% and 8.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

908 Devices Reports First Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for...

11 months ago - Business Wire

908 Devices Advances MX908 Handheld Device Capabilities

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced updates to its MX908...

11 months ago - Business Wire

908 Devices Partners with Key Biomanufacturing Innovation Center

BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, is partnering with the Advanced Mammalian Biomanufa...

11 months ago - Business Wire

908 Devices and CPI Team on Cell Culture Media Optimization for Improved Process Control in Bioprocessing Applications

BOSTON--(BUSINESS WIRE)--908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, is collaborating with UK-based, deep-tech innovatio...

1 year ago - Business Wire